Roivant Sciences Ltd.
ROIV
Rangering i aksjer
#978
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company... Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.
Aksjekurs
$33.73
Sist synkronisert: 2026-07-31
Markedsverdi
$24.37B
Endring (1 dag)
-2.28%
Endring (1 år)
88.77%
Land
GB
Handel Roivant Sciences Ltd. (ROIV)
Kategori
Healthcare
Historikk for aksjesplitt for Roivant Sciences Ltd. (ROIV)
Aksjen Roivant Sciences Ltd. (symbol: ROIV) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én ROIV-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 ROIV-aksjer.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én ROIV-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 ROIV-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
